Forgetting a name mid-sentence at fifty(Menopausal Brain Fog) is frightening in a way it wasn’t at thirty. The fear usually isn’t about the word — it’s about what the word might mean.
The research on this is unusually reassuring, and specific enough to be useful.
It’s measurable, not imagined
The first thing worth knowing is that this shows up on testing.
Just over 60% of women report cognitive difficulties during the menopause transition[1], and estimates of self-reported decline in perimenopause run 44% to 62%[2].
More importantly, those subjective reports link to performance on tests of memory, recall and processing[1].
SWAN — the Study of Women’s Health Across the Nation, which followed thousands of women for over two decades — quantified the pattern. Among 16,065 women aged 40 to 55[3]:
- 31% of premenopausal women reported forgetfulness
- 44% in early perimenopause
- 41% in late perimenopause
- 41% postmenopausal
And the measured declines in verbal memory and processing speed were independent of normal ageing[4].
So this isn’t a matter of women misattributing ordinary ageing to menopause. Menopause itself is a factor.
Which functions, and which don’t
The changes are specific rather than general.
Affected: verbal memory (learning and recalling new information), verbal fluency (quickly retrieving words), processing speed, attention, working memory[1][4].
That maps directly onto the reported experience — difficulty remembering names or finding the right word in conversation[1].
Not affected: higher-order skills including reasoning, problem-solving and strategic thinking remain intact[5].
And the scale matters. Even when performance dips, scores still fall within the normal range[5]. An International Menopause Society white paper notes that about 11 to 13% of women show clinically significant impairment, while the vast majority remain within normal function[4].
| Affected | Preserved |
| Verbal memory | Reasoning |
| Verbal fluency (word retrieval) | Problem-solving |
| Processing speed | Strategic thinking |
| Attention, working memory |
[Table 1] What changes and what doesn’t · Source: Synthesis of related studies[1][4][5]
The trajectory
This is the part most worth knowing, and it needs stating carefully.
SWAN found that the perimenopausal decrement appears to be time-limited[6]. The specific observation is elegant: normally, repeated cognitive testing produces improvement with practice. In perimenopause, that improvement with practice was not seen — and it returned in early postmenopause[6].
The learning ability came back.
Other analyses agree on direction. Scores that changed during the transition normalized in the postmenopausal period, returning to the premenopausal pattern[3]. A 2025 review found evidence of partial grey matter recovery postmenopause[4].
But the picture isn’t uniformly complete recovery, and it would be wrong to imply otherwise.
The Penn Ovarian Aging study found that difficulties in verbal learning persist in postmenopause while difficulties in verbal memory resolve[7]. And the authors note a real limitation: these participants were not followed well into postmenopause[7].
So: SWAN suggests change limited to perimenopause; Penn suggests partial persistence. Both were conducted properly. The honest summary is that the trajectory is toward recovery, with the completeness still being established.
What the literature does agree on is the interpretation. The natural history suggests an aetiology related to sex steroid hormone changes and menopause symptoms, and not an early phase of a dementing disorder[7].
Why the dementia fear arises
The overlap is genuine, which is why reassurance needs to be specific rather than dismissive.
Similar symptoms present in menopause and early Alzheimer’s disease — forgetfulness and word-finding difficulties[1].
Two things distinguish them.
Young-onset dementia, beginning before 65, is not common absent a family history of early-onset dementia[1].
And the trajectory differs. SWAN documented declines that partially reversed in postmenopause — a pattern that directly contradicts early neurodegeneration, which progresses rather than recovering[8].
There’s also a structural problem worth naming. Neurologists are generally not trained in menopause medicine, and gynaecologists rarely administer cognitive assessments[8]. Women can fall between the two.
That’s an argument for mentioning menstrual cycle changes, hot flashes and sleep disruption when raising cognitive concerns — the context that makes the pattern interpretable.
What else is in the mix
Hormones aren’t acting alone, and the other contributors are more addressable.
Sleep. Sleep difficulties are associated with cognitive difficulties at menopause, and while causation at menopause specifically isn’t established, sleep deprivation studies provide robust evidence of a causal role in verbal learning and memory difficulties[7].
Night sweats disrupt sleep. Disrupted sleep impairs exactly the functions affected here.
Mood. Depressive and anxiety symptoms are linked to cognitive symptoms, though whether treating them produces a memory rebound isn’t yet known[7]. SWAN found women with depressive symptoms performed less well on processing speed[6].
This matters practically because sleep and mood are treatable in ways that hormonal transition timing is not.
And as covered in the cognitive screening post, other causes — thyroid dysfunction, B12 deficiency, medication effects — produce overlapping symptoms and are worth excluding.
On hormone therapy
The evidence here is genuinely mixed and this post won’t resolve it.
One position notes that hormone therapy does not appear to have a clear benefit on cognitive function, with evidence remaining limited[1].
Another describes the critical window hypothesis — that estrogen therapy initiated during perimenopause or early postmenopause may differ in effect from initiation more than ten years after menopause. WHIMS enrolled women aged 65 to 79, well past that window, and showed no cognitive benefit; KEEPS, enrolling women within three years of menopause, reported improved verbal memory and mood[8].
Nothing here is a recommendation. Hormone therapy decisions span many outcomes beyond cognition and belong entirely with a clinician, as covered in the menopause claims posts.
What’s reasonable to do
Name it accurately when you raise it. “Word-finding difficulty and slower processing since my periods became irregular” gives a clinician the pattern. “I think I’m losing my memory” doesn’t.
Address sleep. It’s the most modifiable contributor with the clearest causal evidence.
Rule out the overlapping causes. Thyroid, B12, medication review.
Be sceptical of cognitive supplements marketed at this transition. As covered in the cognitive trials post, this is a field where trials are structurally underpowered — and the natural trajectory here is toward improvement anyway, which makes any intervention look effective.
That last point deserves emphasis. If the pattern recovers on its own in early postmenopause, anything taken during that period will appear to have worked.
Closing
Two findings stand out from this literature.
The complaints are validated. Subjective difficulty maps onto measurable decline in specific functions, independent of ageing. Women reporting this are describing something real.
And the direction is toward recovery. SWAN’s observation about practice effects is the clearest version — the ability to improve with repeated testing disappeared during perimenopause and returned afterward. Whether recovery is complete remains under study, with Penn data suggesting some verbal learning difficulty persists.
What the evidence doesn’t support is the fear that usually accompanies the symptom. A pattern that partially reverses is not the pattern neurodegeneration follows.
Which makes this one of the few topics in this series where the most useful thing is reassurance — provided it’s the specific kind, not the dismissive kind.
Key Terms
- Perimenopause — the transition years before periods stop, when hormone levels fluctuate widely.
- Verbal memory — learning and recalling information presented in words.
- Verbal fluency — how quickly words can be retrieved from memory.
- Processing speed — how fast mental tasks are performed.
- Practice effect — the improvement normally seen when the same cognitive test is repeated.
- Young-onset dementia — dementia beginning before age 65.
At a Glance
- Just over 60% of women report cognitive difficulties during the transition; estimates range 44–62%
- SWAN (16,065 women): forgetfulness reported by 31% premenopausal, 44% early perimenopause, 41% postmenopausal
- Declines in verbal memory and processing speed were independent of normal ageing
- Affected: verbal memory, verbal fluency, processing speed, attention. Preserved: reasoning, problem-solving, strategic thinking
- Scores generally remain within the normal range; about 11–13% show clinically significant impairment
- SWAN: the practice effect disappeared in perimenopause and returned in early postmenopause
- Penn Ovarian Aging: verbal memory difficulties resolve but verbal learning difficulties persist postmenopause
- The natural history suggests hormonal aetiology, not an early dementing disorder
※ This article is for general information and does not replace medical assessment, diagnosis or treatment, and nothing here is a recommendation for or against hormone therapy. Cognitive symptoms have many possible causes including thyroid dysfunction, nutrient deficiency, medication effects, depression and sleep disorders. If cognitive changes are worsening, interfering with daily function, or accompanied by disorientation or personality change, seek medical assessment rather than attributing them to menopause.
References
- “‘Brain fog’ during menopause is real – it can disrupt women’s work and spark dementia fears”, The Conversation (60% figure; affected domains; young-onset dementia context; hormone therapy evidence), https://theconversation.com/brain-fog-during-menopause-is-real-it-can-disrupt-womens-work-and-spark-dementia-fears-173150
- “Brain Fog During Menopause: Understanding What’s Going On”, Utah State University Extension (44–62% prevalence estimates), https://extension.usu.edu/midlife-health-menopause/blog/brain-fog-during-menopause
- “Menopause and cognitive impairment: A narrative review of current knowledge”, PMC (SWAN 16,065 women; normalization postmenopause; UK cohort findings), https://pmc.ncbi.nlm.nih.gov/articles/PMC8394691/
- “Menopause Brain Fog: Causes, Duration, and Relief”, Samphire Neuroscience (independence from ageing; IMS 11–13% figure; 2025 grey matter review), https://www.samphireneuro.com/en-gb/blog/does-menopause-cause-brain-fog
- “Menopause brain fog is real — here’s what’s going on”, Yahoo Health (preserved higher-order function; scores within normal range), https://health.yahoo.com/your-body/womens-health/menopause/article/menopause-brain-fog-is-real-164729067.html
- SWAN Fact Sheet, “Memory and Cognition During and After the Menopause Transition”, Study of Women’s Health Across the Nation (practice effect finding; depressive symptoms and processing speed), https://www.swanstudy.org/wps/wp-content/uploads/2023/04/SWAN-Fact-Sheets-Cognition.pdf
- “Brain fog in menopause: a health-care professional’s guide for decision-making and counseling on cognition”, Climacteric (Penn Ovarian Aging findings; sleep and mood evidence; aetiology), https://www.tandfonline.com/doi/full/10.1080/13697137.2022.2122792
- “Perimenopause Brain Fog vs. Dementia: 7 Differences”, Health High Road (partial reversal; specialty gap; critical window hypothesis, WHIMS and KEEPS), https://www.healthhighroad.com/womens-health/perimenopause-brain-fog-vs-dementia/78181